Comparing the accuracy of Intraoral scanning (IOS) versus stereophotogrammetry (SPG) for impressions of dental implants for toothless patients

ISRCTN ISRCTN12501259
DOI https://doi.org/10.1186/ISRCTN12501259
Secondary identifying numbers Version 01
Submission date
22/03/2021
Registration date
13/10/2021
Last edited
04/10/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
The purpose of this project is to compare the accuracy of two digital impression techniques that can be used to create dental prosthetics to replace missing teeth. Defining the level of accuracy of these technologies will allow dentists to improve the workflow for creating these prosthetics and reduce the discomfort for patients. Traditionally these prosthetics are created using a plaster impression of the mouth which is then used as a mould to create the prosthetic. The ongoing development of digital technologies led to a more accurate and sophisticated way to achieve the exact 3D position of dental implants even in completely toothless jaws. Intraoral digital optical scanning (IOS) has been claimed as an alternative to the conventional implant impression even though the complete-arch implant impression by means of IOS is still considered one of the most challenging. Stereophotogrammetry (SPG) technology uses a double stereo camera to detect where the scan bodies are positioned.

Who can participate?
Healthy adults requiring a complete-arch implant-supported fixed dental prosthesis (FDP) of the upper and lower jaw

What does the study involve?
Eligible participants will have a plaster implant impression made of the area of their mouth where the teeth are missing and so a prosthetic is required. A plaster implant impression is currently considered the gold standard for this procedure and will be used to make the models for the prosthetic to be produced. Following this digital impressions will be taken using both SPG and IOS techniques to scan the mouth. The digital impressions will be compared by the researcher.

What are the possible benefits and risks of participating?
It is hoped that this study will benefit future patients by improving the prosthetic workflow and reducing patient discomfort.

Participation in the study is completely voluntary and participants can withdraw at any time.

Where is the study run from?
Policlinico Tor Vergata (Italy)

When is the study starting and how long is it expected to run for?
From January 2021 to October 2021

Who is funding the study?
Investigator-initiated and funded

Who is the main contact?
Dr Paolo Carosi, carosipaolo29@gmail.com

Contact information

Dr Paolo Carosi
Public

Via della Ricerca scientifica 1
Rome
00133
Italy

ORCiD logoORCID ID 0000-0002-2442-1091
Phone +39 3277998699
Email Paolo.carosi@alumni.uniroma2.eu
Dr Lorenzo Arcuri
Scientific

Via della Ricerca scientifica 1
Rome
00133
Italy

ORCiD logoORCID ID 0000-0002-6152-3337
Phone +3928849818
Email lorenzo.arcuri@uniroma2.it

Study information

Study designInterventional non-randomized study
Primary study designInterventional
Secondary study designNon randomised study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet 39675_PIS_09Dec2019.pdf
Scientific titleIntraoral scanning (IOS) versus stereophotogrammetry (SPG) for complete-arch implant impression: A prospective in vivo study on 15 edentulous jaws
Study acronymIOSVSSPG
Study objectivesTo assess the accuracy of IOS and stereophotogrammetry for complete-arch implant impressions in vivo.
Ethics approval(s)Approved 28/10/2020, Independent Ethical Committee Policlinico Tor Vergata (Viale Oxford, 81, 00133 Roma RM, Italy; +39 06-2090 0035; alessandra.nistri@ptvonline.it), ref: 203.20
Health condition(s) or problem(s) studiedImplant-supported complete arch restorations of edentulous jaw
InterventionThe recruited patients of our study received a full-arch implant supported rehabilitation by means of a screw-retained fixed prosthesis in the last 3 years. After the Ethical Committee approval we scanned with IOS and with SPG the patients and obtained STL files, which have been analyzed and superimposed in order to obtain accuracy data. There will be no follow-up of patients.

Assuming Euclidean distance as primary measure of discrepancy, the aim of this study will be to determine whether stereophotogrammetry significantly increases the expected accuracy in comparison to IOS.

Reference scan:
Implant transfers were screwed onto the implants and gypsum impressions were taken. Consequently, the impressions were poured and digitized by means of a structured blue light 3D optical desk scanner (E4, 3Shape, Copenaghen, Denmark) with a declared accuracy of 4 μm (ISO 12836), properly calibrated before the scanning, in order to achieve a standard tessellation language (STL) file to be used as reference. The digital file obtained was used also as a master model for the definitive complete-arch rehabilitation.

Test scans:
The IOS device investigated was a cabled pen grip (Trios3, 3Shape A/S, Copenhagen, Denmark) with the software version 1.6.10.1. It is a powder-free scanner, based on confocal microscopy laser technology. The SPG device investigated was The PICcamera® (PICdental, Madrid, Spain) is a stereo-camera that records implant positions in the mouth by means of photogrammetry. It comprises two CCD cameras specially designed and optimized for clinical use, which accurately determine the position of the implants by means of the identification of abutments screwed on implants with unique individual coding (PICabutment®, PICdental). One operator, an expert in digital impressions recorded 2 impressions with the IOS and the SPG on each patient according to the guidelines of the device producers.

Data processing and accuracy assessment:
The 30 test STL files were aligned to the reference scan with dedicated software (Geomagic Studio 12, 3DSystems, Rock Hill, SC, USA), according to a 0.01 mm alignment tolerance, and 2 alignment optimizations were accomplished after the file superimposition. At last, linear and angular deviations between each test scan and the reference scan were measured for any analogue, analyzing the previously superimposed files through a dedicated measurement software (Hyper Cad S, Cam HyperMill, Open Mind Technologies, Milano, Italy). Linear deviations were assessed for each analogue on the three space axis (X longitudinal, Y lateral, and Z vertical). Negative and positive values depend on the alignment of each test scan with the reference scan and, considering the reference axis system used, must be interpreted as follows: negative values on the X, Y, and Z axis featured a scan body positioned frontward, left, and downward respectively, while the positive ones are in the opposite direction on each axis. 3D deviation was calculated using Euclidean distance. Angular deviations were assessed as the angles formed by the two lines passing perpendicularly through the centers of the test image and the reference image of each implant.
Intervention typeDevice
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)
Primary outcome measureAccuracy measured by analyzing linear and angular deviations between each test scan and the reference scan using a dedicated measurement software (Hyper Cad S, Cam HyperMill, Open Mind Technologies, Milano, Italy)
Secondary outcome measuresThe effect of stereophotogrammetry versus IOS, adjusting for possible confounding factors, will be measured using the General Linear Model at multivariate analysis
Overall study start date08/01/2021
Completion date15/10/2021

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants15 arches (84 implants)
Key inclusion criteria1. Healthy patients aged ≥18 years
2. Full mouth bleeding and full mouth plaque index lower than or equal to 25%
3. Bone height for at least 10 mm long implants
4. Bone width of at least 5 mm and 6 mm for narrow (NP 3.75/3.5 mm) and regular (RP 4.3 mm) implants, respectively
5. Fresh extraction sockets with an intact buccal wall
6. At least 4 and 5 mm of bone beyond the root apex in the mandible and maxilla
7. Minimal insertion torque of 45 Ncm
Key exclusion criteria1. General medical (American Society of Anesthesiologists, ASA, class III or IV) and/or psychiatric contraindications
2. Pregnancy and/or breastfeeding
3. Any interfering medication such as steroid therapy or bisphosphonate therapy
4. Alcohol and/or drug abuse
5. Heavy smoking (>10 cigarettes/day)
6. Radiation therapy to head or neck region within 5 years
7. Untreated periodontitis
8. Acute and chronic infections of the adjacent tissues or natural dentition
9. Severe maxillomandibular skeletal discrepancy
10. High and moderate parafunctional activity
11. Absence of opposite teeth
Date of first enrolment29/03/2021
Date of final enrolment30/05/2021

Locations

Countries of recruitment

  • Italy

Study participating centre

Policlinico Tor Vergata
Viale Oxford, 81
Roma
00133
Italy

Sponsor information

University of Rome Tor Vergata
University/education

Via Montpellier, 1
Rome
00133
Italy

Phone +39 (0)6 7259 6798
Email segr-studenti-odonto@med.uniroma2.it
Website http://web.uniroma2.it/home.php?newlang=italian
ROR logo "ROR" https://ror.org/02p77k626

Funders

Funder type

Industry

Itesi s.r.l.

No information available

Results and Publications

Intention to publish date15/10/2021
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study will be available upon request from the corresponding author Paolo Carosi (Paolo.carosi@alumni.uniroma2.eu) as raw data from the publication date of the article for 1 year.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 09/12/2019 04/10/2021 No Yes

Additional files

39675_PIS_09Dec2019.pdf

Editorial Notes

04/10/2021: Trial’s existence confirmed by Independent Ethical Committee Policlinico Tor Vergata.